| Series |
Advances in oncology ; v. 1
Advances in oncology ; v. 1. ^A1021234
|
| Contents |
Part I: Sexuality after cancer -- Out in the open: addressing sexual health after cancer / Sharon L. Bober -- Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers / Ellen T. Matloff, Rachel E. Barnett, and Sharon L. Bober -- Concerns about sexuality after breast cancer / Patricia Fobair and David Spiegel -- Medical and psychosocial aspects of fertility after cancer / Christine Duffy and Susan Allen -- Sexual rehabilitation after localized prostate cancer: current interventions and future directions / David M. Latini ... [et al.] -- Sexual side effects and prostate cancer treatment decisions: patient information needs and preferences / Sara J. Knight and David M. Latini -- Interventions for sexuality after pelvic radiation therapy and gynecological cancer / Anne Katz -- A review of couple-based interventions for enhancing women's sexual adjustment and body image after cancer / Jennifer L. Scott and Karen Kayser -- Sexuality after hematopoietic stem cell transplantation / Jean C. Yi and Karen L. Syrjala -- Sexual functioning after cancer in sexual minority women / Ulrike Boehmer, Jennifer Potter, and Deborah J. Bowen -- In sickness and in health: maintaining intimacy after breast cancer recurrence / Barbara L. Andersen -- Sexual health comunication during cancer care: barriers and recommendations / Elyse R. Park, Rebecca L. Norris, and Sharon L. Bober -- |
| Contents |
Part II: Hodgkin's lymphoma -- Hodgkin's lymphoma: an overview / Dan L. Longo -- Current insight on trends, causes, and mechanisms of Hodgkin's lymphoma / Neil E. Caporaso ... [et al.] -- Clinical manifestations and natural history of Hodgkin's lymphoma / Joseph M. Connors -- Histopathology of Hodgkin's lymphoma / Franziska C. Eberle, Haresh Mani, and Elaine S. Jaffe -- Hodgkin's lymphoma--patients assessment and staging / Mary K. Gospodarowicz -- Combined modality treatment of Hodgkin's lymphoma / Beate Klimm and Andreas Engert -- Role of chemotherapy in Hodgkin's lymphoma / Pamela Seam ... [et al.] -- Role of radiation therapy in Hodgkin's lymphoma / Joachim Yahalom -- Salvage therapy for Hodgkin's lymphoma / Fahd Quddus and James O. Armitage -- Late effects of Hodgkin's disease and its treatment / Andrea K. Ng and Peter M. Mauch -- |
| Contents |
Part III: Management of peritoneal carcinomatosis from colorectal and appendiceal malignancy -- Peritoneal surface malignancies: a real challenge for surgeons / Franc̦ois Noël Gilly -- Progress in the management of carcinomatosis / Paul H. Sugarbaker -- Imaging of peritoneal carcinomatosis / Santiago González-Moreno ... [et al.] -- Laparoscopy in the management of peritoneal carcinomatosis / Alfredo Garofalo and Mario Valle -- Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve / Faheez Mohamed and Brendan J. Moran -- Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence / Jeremie H. Lefevre and Dominique M. Elias -- Surgical techniques in visceral resection and peritonectomy procedures / Philip Bao and David Bartlett -- Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy / Vic J. Verwaal -- Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy / Kurt Van Der Speeten, Oswald A. Stuart, and Paul H. Sugarbaker -- Epithelial appendiceal neoplasms / Paul H. Sugarbaker -- Patient selection for a curative approach to carcinomatosis / Pompiliu Piso ... [et al.] -- Management of peritoneal carcinomatosis from colorectal cancer: current state of practice / Eddy Cotte ... [et al.] -- Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea / Jesus Esquivel -- |
| Contents |
Part IV: Charged particle therapy -- Particle therapy in all its parts / Benjamin Movsas and Theodore S. Lawrence -- Biology of charged particles / Eleanor A. Blakely and Polly Y. Chang -- Charged particle therapy: the physics of interaction / Antony J. Lomax -- Technology for proton therapy / Jacob Flanz and Alfred Smith -- Proton beam therapy in pediatric oncology / Thomas E. Merchant -- The clinical experience with particle therapy in adults / Daniela Schulz-Ertner -- Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer / Jason A. Efstathiou, Alexei V. Trofimov, and Anthony L. Zietman -- Current clinical evidence for proton therapy / Michael Brada, Madelon Pijls-Johannesma, and Dirk de Ruysscher -- Comparison of carbon ions versus protons / Uli Weber and Gerhard Kraft -- Proton beam therapy and the convoluted pathway to incorporating emerging technology into routine medical care in the United States / Michael L. Steinberg and Andre Konski -- |
| Contents |
Part V: Monitoring of therapeutic responses to cancer treatment -- Monitoring of therapeutic response to cancer treatment / Tito Fojo -- Tumor shrinkage and objective response rates: gold standard for oncology efficacy screening trials, or an outdated end point? / Penelope Bradbury and Lesley Seymour -- Response rates: a valuable signal of promising activity? / Xavier Pivot ... [et al.] -- Stable disease is not preferentially observed with targeted therapies and as currently defined has limited value in drug development / Tatiana Vidaurre ... [et al.] -- Stable disease is a valid end point in clinical trials / r Anthony W. Tolcher -- Progression-free survival is simply a measure of a drug's effect while administered and is not a surrogate for overall survival / Julia Wilkerson and Tito Fojo -- Progression-free survival: gaining on overall survival as a gold standard and accelerating drug development / David Lebwohl ... [et al.] -- Overall survival: a gold standard in search of a surrogate: the value of progression-free survival and time to progression as end points of drug efficacy / Sen H. Zhuang, Liang Xiu, and Yusri A. Elsayed -- Overall survival: still the gold standard: why overall survival remains the definitive end point in cancer clinical trials / James J. Driscoll and Oliver Rixe -- Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development / Daniel S. W. Tan ... [et al.] -- Use of meta-analysis for the validation of surrogate endpoints and biomarkers in cancer trials / Marc Buyse -- Other paradigms: better treatments are identified by better trials: the value of randomized phase II studies / Manish R. Sharma, Michael L. Maitland, and Mark J. Ratain -- Other paradigms: randomized discontinuation trial design / Walter Stadler -- Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance / Peter C. Trask, Ming-Ann Hsu, and Richard McQuellon -- Other paradigms: growth rate constants and tumor burden determined using computed tomography data correlate strongly with the overall survival of patients with renal cell carcinoma / Wilfred D. Stein ... [et al.] -- |
| Contents |
Part VI: New therapies for myeloma: impact on survival -- The evolving treatment paradigm in multiple myeloma / Kenneth C. Anderson -- Risk stratification in the era of novel therapies / Jesus San-Miguel, M. Victoria Mateos, and Norma C. Gutierrez -- The importance of complete response in outcomes in myeloma / Ajay Nooka, Jonathan Kaufman, and Sagar Lonial -- Novel therapies in multiple myeloma for newly diagnosed nontransplant candidates / Sigurdur Yngvi Kristinsson, Ola Landgren, and Vincent S. Rajkumar -- Integrating novel therapies in the transplant paradigm / Jean-Luc Harousseau -- Novel agents for relapsed and/or refractory multiple myeloma / Sheeba K. Thomas, Tiffany A. Richards, and Donna M. Weber -- Evolving role of novel agents for maintenance therapy in myeloma / Valeria Magarotto and Antonio Palumbo -- Novel immunotherapies / Qing Yi -- Future novel single agent and combination therapies / Diana Cirstea, Sonia Vallet, and Noopur Raje. |
| Local note | Laupus-WCP |
| Bibliography note | Includes bibliographical references and index. |
| LCCN | 2010017159 |
| ISBN | 9781451103144 (alk. paper) |
| ISBN | 145110314X (alk. paper) |
